Is limitation of infarct size in the rabbit by ischaemic preconditioning reversible with glibenclamide?
Infarct size reduction in the rabbit via ischaemic preconditioning is reversible with the coadministration of glibenclamide.
This study demonstrated an association between eNOS and ACE genes in increasing PAD susceptibility in smokers, thus providing evidence for a gene-environment interaction in modulating predisposition to the disease.